Characterization of β2-glycoprotein I binding to phospholipid membranes

Thrombosis and Haemostasis

Volumn 80, Issue 4, 1998, Pages 610-614

  Harper, Mark F ^a   Hayes, Peter M ^a   Lentz, Barry R ^a   Roubey, Robert A S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CALCIUM ION; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; GLYCOPROTEIN;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; HUMAN; IONIC STRENGTH; LIGHT SCATTERING; MEMBRANE VESICLE; PATHOPHYSIOLOGY; PHOSPHOLIPID MEMBRANE; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; ARTIFICIAL MEMBRANE; CHEMISTRY;

BETA 2-GLYCOPROTEIN I; GLYCOPROTEINS; HUMANS; MEMBRANES, ARTIFICIAL; PHOSPHOLIPIDS; PROTEIN BINDING;

EID: 0031593870     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-62.
2. 2,-glycoprotein I in the absence of phospholipid. Importance of antigen density and bivalent binding. J lmmunol 1995; 154: 954-60.
3. 2,-glycoprotein I. Proc Natl Acad Sci USA 1984; 81: 3640-4.
4. Steinkasserer A, Estaller C, Weiss EH, Sim RB, Day AJ, Complete nucleotide and amino acid sequence of human beta-2-glycoprotein I. Biochem J 1991; 277: 387-91.
5. 2,-glycoprotein I). Gene 1991; 108: 293-8.
6. 2,-GPI in alteration of anticardiolipin binding. Int Immunol 1991; 3: 1217-21.
7. 2,-glycoprotein I cDNA. FEBS Lett 1991; 289: 183-6.
8. Reid KBM, Bentley DR, Campbell RD, Chung LP, Sim RB, Kristensen T, et al. Complement system proteins which interact with C3b or C4b: a superfamily of structurally related proteins. Immunol Today 1986; 7: 230-4.
9. 2:-glycoprotein 1 (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984; 16: 511-5.
10. 2,-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions. J Biochem 1980; 11: 265-70.
11. 2,-glycoprotein I on the dextran sulfate and sulfatide activation of the contact system (Hageman factor system) in the blood coagulation. Int J Biochem 1988; 20: 787-92.
12. 2:-glycoprotein I critical for lipid binding and anti-cardiolipin cofactor activity. Proc Natl Acad Sci USA 1993; 90: 2141-5.
13. 2n-glyccprotein I contains a phospholipid binding site (cys281-cys288), and a region recognised by anticardiolipin antibodies. J Immunol 1994; 152: 653-9.
14. 2,-glycoprotein I. FEBS Lett 1992; 313: 193-7.
15. 2,-glycoprotein I to cardiolipin. Biochem J 1995; 310: 315-21.
16. 2-glyroprotein I mediated by the kringle IV domain. Blood 1997; 90: 1482-9.
17. 2-glycoprotein I. Biochim Biophys Acta 1986; 884: 142-9.
18. 2-glycoprotien I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.
19. 2-glycoprotein I. J Clin Invest 1992; 90: 1100-4.
20. 2,-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985; 66: 1086-91.
21. 2-glycoprotein-I (apo H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 1987; 63: 109-14.
22. 2-glycoprotein I of the factor Xa generating activity of platelets. Thromb Haemost 1993; 70: 342-5.
23. 2,-glycoprotein I deficiency and the risk of thrombosis. Thromb Haemost 1992; 67 :649-53.
24. 2,-glycoprotein I inhibit phospholipid dependent coagulation reactions. Thromb Haemost 1993; 70: 598-602.
25. Nelsestuen GL, Lim TK. Equilibria involves in prothrombin- and blood-clotting factor X-membrane binding. Biochemistry 1977; 16: 4164-71.
26. Cutsforth GA, Whitaker RN, Hermans J, Lentz BR. A new model to describe extrinsic protein binding to phospholipid membranes of varying composition: application to human coagulation proteins. Biochemistry 1989; 28: 7453-61.
27. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein I, a member of the lipocortin family. J Biol Chem 1989; 264: 7944-9.
28. Barenholz Y, Gibbes D, Litman BJ, Goll J, Thompson TE, Carlson FD. A simple method for the preparation of homogeneous phospholipid vesicles. Biochemistry 1977; 16: 2806-10.
29. Chen PS, Toribara TY, Warner H. Microdetermination of phosphorus. Anal Chem 1956; 28: 1756-8.
30. Lentz BR, Mclntyre GF, Parks DJ, Yates JC, Massenburg D. Bilayer curvature and certain amphipaths promote poly(ethylene glycol)-induced fusion of dipalmitoylphosphatidylcholine unilamellar vesicles. Biochemistry 1992; 31: 2643-53.
31. Lentz BR, Zhou CM, Wu JR. Phosphatidylserine-containing membranes alter the thermal stability of prothrombin's catalytic domain: a differential scanninb calorimetric study. Biochemistry 1994; 33: 5460-8.
32. Koppaka V, Lentz BR. Binding of bovine factor Va to phosphatidylcholine membranes. Biophys J 1996; 70: 2930-7.
33. Cutsforth GA, Koppaka V, Krishnaswamy S, Wu JR, Mann KG, Lentz BR. Insights into the complex association of bovine factor Va with acidic-lipidcontaining synthetic membranes. Biophys J 1996; 70: 2938-49.
34. 2-glycoprotein I in its interaction with cardiolipin. J Biochem 1995;118: 129-36.
35. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994; 84: 2854-67.
36. 2:-glycoprotein I complexes to lipid membranes. Biochemistry 1996; 35: 13833-42.
37. 2-glycoprotein I (β2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the β2GPI binding to phospholipids. J Clin Invest 1997; 99: 2260-8.
38. Arnout J, Wittevrongel C, Vanrusselt M, Hoylaerts M, Vermylen J. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces. Thromb Haemost 1998; 79: 79-86.
39. Walker FJ. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128-31.
40. Krishnaswamy S, Mann KG. The binding of factor Va to phospholipid vesicles. J Biol Chem 1988; 263: 5714-23.